Here, we show that 7HP349 integrin activation reversed CXCL12’s effects on tumor-specific CD8+ Teffs, promoting CD8+ Teff persistence and functionality, as evidenced by an increase in IFN-γ secretion. The gene discussed is CD8A; the disease is neoplasm.